Third, this study primarily relied on clinical and pathological data and did not investigate the molecular mechanisms underlying coagulation abnormalities and tumor rupture, such as VHL gene mutations or dysregulation of the HIFs pathway, which have been implicated in the pathogenesis and progression of clear cell RCC. The gene discussed is VHL; the disease is neoplasm.